The NPs loaded with DOX and Bcl-2-targeting siRNA showed tumor accumulation in HepG2/adriamycin (ADM) tumor-bearing mice, resulting in reduced tumor growth and increased survival compared to controls [76]. Here, BCL2 is linked to neoplasm.